A Subcellular Keap1-Nrf2 Disruption Strategy for Atopic Dermatitis Therapy.

Zhang Z, Wu J, Liu J, Chan DS, Wong CY, Wang J, Leung CH, Wang W

Open source

DOI
10.1021/acs.jmedchem.6c00772
Published
2026 Sep 10
Container
Journal of medicinal chemistry
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acs.jmedchem.6c00772,
  title = {A Subcellular Keap1-Nrf2 Disruption Strategy for Atopic Dermatitis Therapy.},
  author = {Zhang Z and Wu J and Liu J and Chan DS and Wong CY and Wang J and Leung CH and Wang W},
  year = {2026},
  journal = {Journal of medicinal chemistry},
  doi = {10.1021/acs.jmedchem.6c00772},
  url = {https://doi.org/10.1021/acs.jmedchem.6c00772}
}

RIS

TY  - JOUR
TI  - A Subcellular Keap1-Nrf2 Disruption Strategy for Atopic Dermatitis Therapy.
AU  - Zhang Z
AU  - Wu J
AU  - Liu J
AU  - Chan DS
AU  - Wong CY
AU  - Wang J
AU  - Leung CH
AU  - Wang W
PY  - 2026
JO  - Journal of medicinal chemistry
DO  - 10.1021/acs.jmedchem.6c00772
UR  - https://doi.org/10.1021/acs.jmedchem.6c00772
ER  - 

APA

Z, Z., J, W., J, L., DS, C., CY, W., J, W., CH, L., & W, W. (2026). A Subcellular Keap1-Nrf2 Disruption Strategy for Atopic Dermatitis Therapy.. Journal of medicinal chemistry. https://doi.org/10.1021/acs.jmedchem.6c00772

Source records